Ion Beam Applications S.A. recalls ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of patients with localized tumors and…
When resuming from a beam pause, the Proton Therapy System does not verify whether the beam range has not been manually modified during the pause and is still the prescribed one. Therefore, if an operator manually…
Read the official notice →- Date
- 2022-03-16
- Country
- United States
- Brand
- Ion Beam Applications
- Product
- ProteusPLUS and ProteusONE- designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other…
- Classification
- Class II
- Units
- IL, KS, LA, FL, MI, OK, PA, NJ, TN, TX, VA, WA Foreign: Belgium, England,…
- Category
- Drugs & medical
- Source
- FDA · Device
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Ion Beam Applications recalls
- 2024-08-28
USIon Beam Applications S.A. recalls IBA Proton Therapy System - PROTEUS 235- Designed to produce and deliver a proton beam for the treatment of patients with localized…
Temporary deactivation of collision detection for Forte Robotic Patient Positioning System occasionally experiences issues
FDA · DeviceIon Beam Applications S.A.IL,LA, NJ, MI,OK, TN, TX, VA, WA Foreign: Czech Republic France Germany Italy…Official notice →- 2024-06-12
- US
Ion Beam Applications S.A. recalls IBA Proton Therapy System - PROTEUS 235 - Designed to produce and deliver a proton beam for the treatment of patients with localized…
Irradiation is not interrupted when some C230 Accelerator Control Unit critical parameters are outside of the defined tolerances
FDA · DeviceIon Beam Applications S.A.Worldwide - US Nationwide distribution in the state of Virginia and the…Official notice → - 2024-05-01
- US
Ion Beam Applications S.A. recalls IBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.
There is a risk of mistreatment as irradiation is not prevented when some safety parameters are out of tolerance.
FDA · DeviceIon Beam Applications S.A.US Nationwide distribution in the states of AR, FL, LA, KS, MI, TX, VA.Official notice → - 2023-11-22
- US
Ion Beam Applications S.A. recalls IBA Proton Therapy System - PROTEUS 235. PTS-11 versions, PTS-12 versions with Orion PPS version OSS6.0. Configured with Orion Patient…
The patient positioning system can perform motions in unexpected directions, creating the potential for crushing of the patient between the patient positioning devices.
FDA · DeviceIon Beam Applications S.A.Worldwide - US Nationwide distribution in the states of Arkansas, Florida,…Official notice → - 2022-06-08
- US
Ion Beam Applications S.A. recalls Proteus235- Proton Therapy System: to produce and deliver a proton beam for the treatment of patients with localized tumors and other…
First layer of Uniform Scanning treatment fields is sometimes irradiated with incorrect Scanning Magnet setpoints resulting in the field size may be smaller than expected and the irradiated area may receive more dose…
FDA · DeviceIon Beam Applications S.A.Worldwide distribution - US Nationwide distribution in the states of IL, VA,…Official notice → - 2022-01-19
- US
Ion Beam Applications S.A. recalls Proteus 235; Version: PTS-8 versions before PTS-8.7.2
Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical…
Other drugs & medical recalls in the United States
- 2022-03-23
- US
Golden State Medical Supply Inc. recalls Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS,…
CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
- US
The Harvard Drug Group recalls hydrALAZINE HCl Tablets, USP, 10 mg, 100 Tablets per carton (10x10 blister packs), Rx only, Distributed by: MAJOR PHARMACEUTICALS,…
Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.
- 2022-03-17
- US
Acme United Corporation Recalls PhysiciansCare Brand Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison…
- 2022-03-16
- US
Envisiontec US Llc recalls PCA 4000 Curing Units, SKU number ACC-06-1000 The PCA 4000 is used for curing industrial resins as well and this recall will not impact…
The PCA 4000 may not fully cure EnvisionTEC dental resins to desired product specifications.
- US
Physio-Control, Inc. recalls HeartSine Samaritan PAD, SAM 350P Semi-Automatic Defibrillator, used with Pad-Pak
Semi-automatic defibrillators shipped out by Stryker without battery and electrode packs.
- US
3-D Matrix, Inc. recalls PuraSinus Absorbable Nasal Hemostat, Part Numbers 651-006
The boxes used by the shipper were not validated for use during transport.